CHS INC - CHSINC 7.1 PERP (CHSCN) Fundamental Analysis & Valuation
NASDAQ:CHSCN • US12542R5063
Current stock price
25.02 USD
+0.02 (+0.08%)
Last:
This CHSCN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHSCN Profitability Analysis
1.1 Basic Checks
- CHSCN had a positive operating cash flow in the past year.
- In the past 5 years CHSCN has always been profitable.
- In the past 5 years CHSCN always reported a positive cash flow from operatings.
1.2 Ratios
- CHSCN's Return On Assets of 2.96% is in line compared to the rest of the industry. CHSCN outperforms 59.77% of its industry peers.
- With a decent Return On Equity value of 5.48%, CHSCN is doing good in the industry, outperforming 60.92% of the companies in the same industry.
- CHSCN has a Return On Invested Capital (0.37%) which is comparable to the rest of the industry.
- The Average Return On Invested Capital over the past 3 years for CHSCN is below the industry average of 7.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 5.48% | ||
| ROIC | 0.37% |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
1.3 Margins
- CHSCN has a Profit Margin (1.75%) which is comparable to the rest of the industry.
- CHSCN's Profit Margin has improved in the last couple of years.
- CHSCN has a Operating Margin (0.21%) which is comparable to the rest of the industry.
- In the last couple of years the Operating Margin of CHSCN has declined.
- Looking at the Gross Margin, with a value of 3.21%, CHSCN is doing worse than 81.61% of the companies in the same industry.
- CHSCN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.21% | ||
| PM (TTM) | 1.75% | ||
| GM | 3.21% |
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
2. CHSCN Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCN is destroying value.
- Compared to 1 year ago, CHSCN has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.10 indicates that CHSCN is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of CHSCN (2.10) is comparable to the rest of the industry.
- CHSCN has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
- CHSCN's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. CHSCN outperforms 63.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.1 |
ROIC/WACC0.07
WACC5.46%
2.3 Liquidity
- CHSCN has a Current Ratio of 1.42. This is a normal value and indicates that CHSCN is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.42, CHSCN is in line with its industry, outperforming 44.83% of the companies in the same industry.
- CHSCN has a Quick Ratio of 1.42. This is a bad value and indicates that CHSCN is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of CHSCN (0.80) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.8 |
3. CHSCN Growth Analysis
3.1 Past
- The Revenue has decreased by -5.74% in the past year.
- Measured over the past years, CHSCN shows a small growth in Revenue. The Revenue has been growing by 4.54% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. CHSCN Valuation Analysis
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- 96.55% of the companies in the same industry are more expensive than CHSCN, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.35 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. CHSCN Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 7.10%, CHSCN is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 2.47, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 88.51% of the companies listed in the same industry.
- CHSCN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.1% |
5.2 History
- CHSCN has been paying a dividend for at least 10 years, so it has a reliable track record.
- CHSCN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
5.3 Sustainability
- CHSCN pays out 27.52% of its income as dividend. This is a sustainable payout ratio.
DP27.52%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCN Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:CHSCN (3/23/2026, 4:30:00 PM)
25.02
+0.02 (+0.08%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-06 2026-01-06
Earnings (Next)03-31 2026-03-31
Inst Owners10.86%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap307.00M
Revenue(TTM)35.03B
Net Income(TTM)613.61M
Analysts0
Price TargetN/A
Short Float %0.67%
Short Ratio4.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.1% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP27.52%
Div Incr Years0
Div Non Decr Years10
Ex-Date03-17 2026-03-17 (0.44375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.52 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 2.35 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.86
FCFYN/A
OCF(TTM)48.25
OCFY192.83%
SpS2855.14
BVpS913.07
TBVpS913.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 5.48% | ||
| ROCE | 0.54% | ||
| ROIC | 0.37% | ||
| ROICexc | 0.38% | ||
| ROICexgc | 0.38% | ||
| OM | 0.21% | ||
| PM (TTM) | 1.75% | ||
| GM | 3.21% | ||
| FCFM | N/A |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score4
Asset Turnover1.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 96.64% | ||
| Cap/Sales | 1.86% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.1% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.8 | ||
| Altman-Z | 2.1 |
F-Score4
WACC5.46%
ROIC/WACC0.07
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.46%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.15%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%
CHS INC - CHSINC 7.1 PERP / CHSCN Fundamental Analysis FAQ
What is the ChartMill fundamental rating of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCN.
What is the valuation status for CHSCN stock?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7.1 PERP (CHSCN). This can be considered as Overvalued.
What is the profitability of CHSCN stock?
CHS INC - CHSINC 7.1 PERP (CHSCN) has a profitability rating of 4 / 10.
Can you provide the financial health for CHSCN stock?
The financial health rating of CHS INC - CHSINC 7.1 PERP (CHSCN) is 3 / 10.